Home » Newsletters » BioWorld

BioWorld

Jan. 27, 1993

View Archived Issues

IMCLONE SIGNS $35 MILLION DEAL WITH CHUGAI

INVEMED EXERCISES OVERALLOTMENT OPTION

RIBI FILES FOR 3 MILLION-SHARE OFFERING

TELIOS COMPLETES OFFERING

VIAGENE FILES FOR IPO

BIOTECH STOCKS SLIP

PFIZER SPECIALTY CHEMICALS RENAMED

CORTECH PLANS PHASE II TRIALS IN SIRS

GENELABS MERGES DIAGNOSTICS DIVISION

DRUG TAILOR-MADE FOR COMMON COLD

COR COMPLETES OFFERING

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 10, 2025.
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol
BioWorld
In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
Merck wins approval FDA in pediatric RSV and steps into CDC uncertainty
BioWorld
With the U.S. FDA’s approval of Enflonsia (cesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...